Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 250 of 2228 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/01/06
End: 10/01/06
Due: 10/01/07
Phase: N/A
Priority: Normal
Start: 01/08/20
End: 09/29/20
Due: 09/29/21
Phase: N/A
Priority: Normal
Start: 01/31/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/25/23
End: 02/13/26
Due: 02/13/27
Phase: N/A
Priority: Normal
Start: 04/20/17
End: 06/29/17
Due: 06/29/18
Phase: N/A
Priority: Normal
Start: 08/31/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/22/23
End: 11/05/26
Due: 11/05/27
Phase: N/A
Priority: Normal
Start: 08/17/17
End: 02/18/20
Due: 02/18/21
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 06/14/22
End: 10/18/22
Due: 10/18/23
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 09/30/13
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 07/05/17
End: 01/12/21
Due: 01/12/22
Phase: N/A
Priority: Normal
Start: 02/28/03
End: 02/28/05
Due: 02/28/06
Phase: N/A
Priority: Normal
Start: 09/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/21/15
End: 10/10/17
Due: 10/10/18
Phase: N/A
Priority: Normal
Start: 07/17/13
End: 03/06/24
Due: 03/06/25
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 08/31/04
End: -
Due: -
A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood
Phase: N/A
Priority: Normal
Start: 05/22/24
End: 07/08/24
Due: 07/08/25